Pharvaris (PHVS) Operating Leases (2021 - 2026)
Pharvaris (PHVS) posted Operating Leases of $623515.7 for Q1 2026, up 344.57% on a QoQ basis from -$254940.7 in Q4 2025, and up 8.49% year-over-year from $574727.6 in Q1 2025.
Pharvaris (PHVS) Operating Leases (2021 - 2026) Analysis & Trends
Pharvaris' Operating Leases history runs 6 years deep, the most recent figure standing at $623515.7 for Q1 2026.
- Quarterly Operating Leases rose 8.49% year-over-year to $623515.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $623515.7 (up 8.49% YoY) and the FY2025 annual result came in at $651432.2, down 5.82% from the prior year.
- Operating Leases was $623515.7 for Q1 2026 at Pharvaris, up from -$254940.7 in the prior quarter.
- Across five years, Operating Leases topped out at $682878.4 in Q4 2024 and bottomed at -$98.3 billion in Q2 2023.
- A 5-year average of -$5.8 billion and a median of $87250.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 90210512.05% — and 2025, when it jumped 655.77%.
- Pharvaris' Operating Leases stood at -$121947.1 in 2022, then tumbled by 94.55% to -$237252.3 in 2023, then soared by 387.83% to $682878.4 in 2024, then plunged by 137.33% to -$254940.7 in 2025, then jumped by 344.57% to $623515.7 in 2026.
- Business Quant data shows PHVS's Operating Leases at $623515.7 in Q1 2026, -$254940.7 in Q4 2025, and $515600.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623,515.72 |
| Dec 31, 2025 | -254,940.66 |
| Sep 30, 2025 | 515,600.06 |
| Jun 30, 2025 | 534,970.94 |
| Mar 31, 2025 | 574,727.57 |
| Dec 31, 2024 | 682,878.41 |
| Sep 30, 2024 | -146,147.76 |
| Jun 30, 2024 | -115,484.35 |
| Mar 31, 2024 | 76,045.32 |
| Dec 31, 2023 | -237,252.28 |
| Sep 30, 2023 | -180,544.91 |
| Jun 30, 2023 | -98.27 Bn |
| Mar 31, 2023 | 170,015.20 |
| Dec 31, 2022 | -121,947.11 |
| Sep 30, 2022 | 87,250.01 |
| Jun 30, 2022 | 108,939.02 |
| Mar 31, 2022 | 137,494.23 |
| Dec 31, 2021 | 172,455.91 |
| Sep 30, 2021 | 202,207.68 |
| Jun 30, 2021 | 227,950.52 |